NEU

ANALYST NOTE: NewMarket Corporation (NEU) Date: 2026-06-13 Analyst: StoryStocks-Native Equity Analyst

1. Structural Readiness

As of the close on June 13, 2026, NewMarket Corporation presents a confirmed coil setup. The structural readiness is actionable, with a conservative entry recorded at $889.04. The current price stands at $909.98, representing an extension of +2.4% above the conservative entry level.

The setup is not merely forming; the breakout signal has fired, indicating that the market has accepted higher valuations relative to the base structure. The ATR at breakout was 3.2%, categorized as productive, suggesting strong structural quality at the moment of the move. Current volatility, measured by the ATR, is 3.1%, also productive, providing a healthy volatility environment for position sizing without the elevated risk associated with extreme volatility buckets. The presence of a confirmed coil serves as a partial positive readiness signal, confirming that the market structure supports the current price action.

2. The Thesis Layer

The primary secular thesis driving conviction is Defense Modernization — Precision Munitions. NewMarket is a direct beneficiary of this theme through its Specialty Materials segment, which supplies critical inputs for solid rocket motors and advanced aerospace propulsion.

• Primary Exposure: The company's acquisition of AMPAC (ammonium perchlorate) and Calca (hydrazine) places it at the center of the supply chain for tactical rockets, strategic missiles, and solid rocket boosters. Management explicitly states that the need for these systems "is anticipated to provide the base demand over the coming five-year period and beyond."
• Secondary Exposure: The company is also a member of the Critical Minerals & Materials theme (Specialty & Advanced Materials). This dual exposure creates a layered defense against sector-specific downturns; while the petroleum additives business faces cyclical headwinds, the defense materials business benefits from long-term government procurement cycles and satellite deployment growth.

The combination of these two themes provides a robust context for conviction. The company is not just a passive participant but an active capacity expander in a constrained market, as evidenced by the $100 million capital investment to increase AMPAC capacity by over 50%.

3. The Business

NewMarket Corporation operates in the Industrials sector, specifically within the Specialty Chemicals industry. The business is bifurcated into two distinct operating segments:

• Petroleum Additives: This segment, historically the core of the business, manufactures lubricant and fuel additives (via Afton) and antiknock compounds (via Ethyl).
• Q1 2026 Performance: Sales were $610 million, a decrease from $646 million in the prior year period.
• Drivers: The decline was attributed to a 7% drop in shipments due to market softness and a strategic decision to exit low-margin business. Operating profit fell to $135 million from $142 million.
• Outlook: Management expects continued impacts from market softness and macroeconomic uncertainty in 2026 but anticipates "solid results" overall. They have implemented price adjustments to offset rising raw material, utility, and logistics costs.
• Specialty Materials: This segment focuses on high-purity materials for defense and aerospace.
• Q1 2026 Performance: Sales reached $58 million, an increase from $54 million in the prior year.
• Drivers: Growth was driven by the inclusion of the Calca business (acquired October 1, 2025) and a favorable shift in shipment mix at AMPAC.
• Strategic Focus: The segment includes production of ammonium perchlorate for solid rocket motors and hydrazine for in-space propulsion.

Financial Health: As of March 31, 2026, the company reported a net debt-to-EBITDA ratio of 1.2x, indicating a conservative capital structure capable of supporting further growth.

4. The Archetype and Conviction

NewMarket fits the Quality Compounder archetype. This classification is supported by:

• Margin Inflector: The strategic reduction of low-margin business in the Petroleum Additives segment, despite top-line pressure, demonstrates a commitment to quality earnings over volume.
• Growth Leader (in niche): The Specialty Materials segment is executing a clear growth strategy through M&A (AMPAC, Calca) and organic capacity expansion (AMPAC line expansion).
• Valuation Context: While forward consensus EPS for FY1 is not explicitly detailed in the provided financial spine (listed as 0), the company's ability to maintain a low debt ratio (1.2x) while investing $1 billion since 2024 into its high-growth segment suggests a disciplined capital allocation framework.

Conviction Stack:

• Thesis Strength: High. The defense demand cycle is structural and long-duration (5+ years).
• Evidence Quality: Strong. Management has provided specific guidance on capacity expansion ($100M capex) and clear segmentation of performance drivers.
• Structural Quality: The ATR metrics (3.2% at breakout, 3.1% current) fall within the "productive" range, indicating a healthy trend without excessive noise.
• Rerating Potential: The market is currently pricing in the transition from a pure cyclical chemical company to a hybrid compounder with a high-growth defense arm. The confirmed coil setup suggests the market is beginning to recognize this re-rating.

5. Invalidation, Strengthening, and Gaps

What would Strengthen the Case:

• Continued growth in the Specialty Materials segment as the AMPAC capacity expansion comes online later in 2026.
• Stabilization or growth in Petroleum Additives shipments, indicating the "market softness" is a temporary cyclical trough rather than a secular decline.
• Further institutional accumulation, as seen with recent buying by Entropy Technologies, Bank of Nova Scotia, and Fifth Third Bancorp.

What would Invalidate the Case:

• A significant deterioration in the net debt-to-EBITDA ratio above 2.0x, suggesting the capital expansion is over-leveraging the balance sheet.
• A failure to execute the AMPAC capacity expansion by the end of 2026, potentially missing the defense demand window.
• A sharp, sustained drop in the price of oil that forces a reduction in global lubricant demand beyond the current "softness."

Gaps in Evidence:

• Forward EPS Consensus: The financial spine indicates a forward consensus EPS of 0 for FY1, which is a data gap. Without a specific earnings estimate, it is difficult to assess the current valuation multiple (P/E) relative to historical norms.
• Q2 2026 Specifics: While news from July 2026 (future relative to the event date of June 13) mentions Q2 results, the specific Q2 2026 financial data is not available in the evidence base as of June 13, 2026. We must rely on Q1 trends and management guidance for the full year.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Confirmed coil breakout with productive ATR; direct beneficiary of 5-year defense demand cycle via AMPAC/Calca; conservative debt ratio of 1.2x supporting capex. Key risks: Petroleum Additives segment remains in a cyclical downturn; execution risk on $100M AMPAC capacity expansion; lack of forward EPS consensus data. Rating boundary: This is a Buy rather than a Strong Buy because the Petroleum Additives segment is currently contracting (-5.5% sales) and the full-year impact of this weakness is not yet fully priced out, creating a drag on overall growth. It would drop to a Hold if the debt ratio were to spike above 2.0x or if the AMPAC expansion faced significant delays. Sizing hint: Position size should reflect the dual-segment nature; overweight the defense exposure but maintain a defensive stance on the cyclical additive business. Expected path: Management expects the Specialty Materials segment to drive growth as the AMPAC line comes online, offsetting the softness in Petroleum Additives. The company will likely continue to rebalance production and adjust prices to manage input costs. Expected horizon: 12 to 18 months for the capacity expansion to fully contribute to earnings and for the cyclical softness in additives to stabilize. Failure mode to watch: A failure to complete the AMPAC capacity expansion by the end of 2026, which would signal an inability to capture the anticipated defense demand surge.